| Stereochemistry | ABSOLUTE |
| Molecular Formula | C27H33N3O4 |
| Molecular Weight | 463.5686 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C[C@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C3=CC=CC=C3
InChI
InChIKey=BLPWNGOQQLJQOL-NRYAXDJKSA-N
InChI=1S/C27H33N3O4/c1-17(2)13-20(15-25(31)32)26(33)30-24(14-21-16-28-23-12-8-7-11-22(21)23)27(34)29-18(3)19-9-5-4-6-10-19/h4-12,16-18,20,24,28H,13-15H2,1-3H3,(H,29,34)(H,30,33)(H,31,32)/t18-,20+,24-/m0/s1
| Molecular Formula | C27H33N3O4 |
| Molecular Weight | 463.5686 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 0.2 nM [Ki] | |||
| 100.0 nM [Ki] | |||
| 500.0 nM [Ki] | |||
| 100.0 nM [Ki] | |||
| 20.0 µM [Ki] |